Affiliations

Canadian Friends of the Hebrew University

Canadian Friends of the Hebrew University (CFHU) has been an integral force in the Hebrew University's rise to international prominence through the establishment of scholarships and funding of cutting-edge research. It has succeeded in its commitment to support Hebrew University's Institute for Medical Research Israel-Canada (IMRIC) by creating key collaborative medical research partnerships between Canada and Israel.

CFHU is a national not-for-profit organization that promotes the awareness, leadership, and financial support of the Hebrew University of Jerusalem.

The organization also facilitates initiatives such as joint Research and Development projects and student or faculty exchanges between Canada and Israel. Such efforts help to ensure that the Hebrew University's 22,000-plus students, scientists, researchers, and scholars of today become Israel's leading contributors of tomorrow, sustaining the nation's greatest asset — the intellectual strength of its people. Founded in 1944 by Canadian philanthropist Allan Bronfman, CFHU has chapters in Montreal, Ottawa, Toronto, Winnipeg, Edmonton, Calgary, and Vancouver.

CFHU has committed to raising $50 million in support of the IMRIC. Through its collaborative fundraising initiatives, CFHU is working to promote and support medical research at IMRIC.

 

The Hebrew University of Jerusalem

The Hebrew University of Jerusalem is a multidisciplinary institution of higher learning and research where intellectual pioneering, cutting-edge scientific discovery, and a passion for learning flourish.

Ranked among the world's leading universities, the Hebrew University is a teaching and research centre of international repute, with ties extending to and from the worldwide scientific and academic community. At the Hebrew University, Israelis of all backgrounds receive a university education where excellence is emphasized, and where special programs and conferences attract students and academics from around the world.

Its mission is three fold: 1) to serve Israel by training its scientific, educational, and professional leadership; 2) to serve the Jewish people by preserving and expanding their cultural, spiritual, and intellectual heritage; and 3) to serve humanity by extending the frontiers of knowledge through research and by developing technologies.

The Hebrew University opened in 1925, 23 years before the State of Israel was established. The first Board of Governors included Albert Einstein, Sigmund Freud, Martin Buber, and Chaim Weizmann.

Research, Innovation and Licensing

Research: Hebrew University researchers are at the forefront of international science — from biotechnology, computer science, and astrophysics to cancer research,  microbiology, solar energy, and genetic engineering — as well as the humanities, including Jewish studies, social sciences, and law.

  • Hebrew Universityhas 100 research centres and more than 4,000 ongoing research projects.
  • Nearly 30 percent of research conducted at the University is eventually commercialized within the high-tech industry.
  • Hebrew University is tied with Oxford University in second place in the number of new European Research Council (ERC) grants garnered; 11 young faculty members received these awards, while 10 of their colleagues were awarded ERC advanced grants.

Innovation:

  • Exelon® — FDA-approved drug for treating Alzheimer's disease and dementia
  • Doxil® — The only cancer medication of Israeli origin currently on the market with an innovative delivery system
  • Cherry Tomatoes — The world's most popular cocktail hybrids for greenhouse production with improved shelf-life, yield, and quality, they have become an industry standard
  • REPEL-CV— FDA-approved bioresorbable film placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the formation of scar tissue
  • EyeQ Chip — A processing system, developed by MobilEye, that analyzes signals from car-mounted cameras to warn drivers of potential road hazards

Licensing: Yissum promotes the transfer of Hebrew University technology for the benefit of society, while maximizing returns to support research, education, and scientific excellence. Yissum ranks among the top technology transfer companies in the world, with revenues that place Hebrew University among the top 15 universities worldwide. Yissum has registered 6,100 patents (132 in 2009 alone), licensed out 480 technologies, and created 68 spin-off companies.